Deals
Nasdaq Sees Israeli Biotech IPOs Tapping the Market This Year
This article is for subscribers only.
More Israeli biotech and technology companies plan to list shares on Nasdaq Inc.’s New York market this year, according to Executive Vice President of Listings Services Nelson Griggs.
Three biotech and one tech company “have done their initial filings” and will be “looking to list sometime this year if the market and investor side cooperates,” Griggs said in an interview from Tel Aviv. “The potential here is enormous but we are not seeing any of the real large ones looking at our market yet,” he said.